Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Nausea × nabiximols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 8 Neoplasms 6 Cancer Pain 4 Marijuana Abuse 2 Signs and Symptoms 1 Parasomnias 1 Neuralgia 1 Nausea 1 Multiple Sclerosis 1 Marijuana Use 1 Diabetes Mellitus 1 Anxiety Disorders 1 1- Cancer Patients During Chemotherapy Treatment 1

Interventions

Dexamethasone 20 Aprepitant 20 Ondansetron 19 Palonosetron 14 Granisetron 11 Calcium Dobesilate 8 Therapeutics 7 dexamethasone acetate 5 Olanzapine 5 Doxorubicin 5 Cyclophosphamide 5 casopitant 4 Acupressure 4 netupitant 3 dolasetron 3 Vincristine 3 Radiotherapy 3 Dronabinol 3 ginger extract 2 fosaprepitant 2 dexamethasone 21-phosphate 2 Tropisetron 2 Surveys and Questionnaires 2 Prochlorperazine 2 Metoclopramide 2 Mesna 2 Ifosfamide 2 Fluorouracil 2 Duration of Therapy 2 Docetaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡